{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:22:32Z","timestamp":1785601352725,"version":"3.56.0"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1989,2,1]],"date-time":"1989-02-01T00:00:00Z","timestamp":602294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1989,2]]},"DOI":"10.1007\/bf03259899","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T11:24:42Z","timestamp":1354188282000},"page":"1-16","source":"Crossref","is-referenced-by-count":18,"title":["Recent Developments in Aluminium Toxicology"],"prefix":"10.1007","volume":"4","author":[{"given":"F. S. E.","family":"Monteagudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. D.","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. I.","family":"Folb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259899_CR1","first-page":"203","volume":"19","author":"P Ackrill","year":"1982","unstructured":"Ackrill P, Day JP, Garstang FM, Hodge KC, Metcalfe PJ, et al. Treatment of fracturing renal osteodystrophy by desferrioxamine. Proceedings of the European Dialysis and Transplant Association 19: 203\u2013207, 1982","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR2","first-page":"S104","volume":"29","author":"P Ackrill","year":"1986","unstructured":"Ackrill P, Ralston AJ, Day JP. Role of desferrioxamine in the treament of dialysis encephalopathy. Kidney International 29: S104\u2013S107, 1986","journal-title":"Kidney International"},{"key":"BF03259899_CR3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(80)92728-2","volume":"2","author":"P Ackrill","year":"1980","unstructured":"Ackrill P, Ralston AJ, Day JP, Hodge KC. Successful removal of aluminium from a patient with dialysis encephalopathy. Lancet 2: 692\u2013693, 1980","journal-title":"Lancet"},{"key":"BF03259899_CR4","first-page":"1609","volume":"313","author":"L Adan","year":"1985","unstructured":"Adan L, Hainline BW, Zackson DA. The importance of accurate and precise aluminium levels. New England Journal of Medicine 313: 1609, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-0-12-135301-8.50016-9","volume-title":"Disorders of mineral metabolism, Vol. I","author":"AC Alfrey","year":"1981","unstructured":"Alfrey AC. Aluminium and tin. In Bonner & Coburn (Eds) Disorders of mineral metabolism, Vol. I, pp. 353\u2013368, Academic Press Inc, New York, 1981"},{"key":"BF03259899_CR6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJM198404263101709","volume":"310","author":"AC Alfrey","year":"1984","unstructured":"Alfrey AC. Aluminium intoxication. New England Journal of Medicine 310: 1113\u20131115, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR7","first-page":"S15","volume":"24","author":"AC Alfrey","year":"1985","unstructured":"Alfrey AC. Dialysis encephalopathy. Clinical Nephrology 24: S15\u2013S19, 1985a","journal-title":"Clinical Nephrology"},{"key":"BF03259899_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0272-6386(85)80085-8","volume":"6","author":"AC Alfrey","year":"1985","unstructured":"Alfrey AC. The case against aluminium affecting parathyroid function. American Journal of Kidney Diseases 6: 309\u2013312, 1985b","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","volume":"294","author":"AC Alfrey","year":"1976","unstructured":"Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. New England Journal of Medicine 294: 184\u2013188, 1976","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198707093170204","volume":"317","author":"P Altmann","year":"1987","unstructured":"Altmann P, Al-Salihi F, Butler K, et al. Serum aluminium levels and erythrocyte dihydropteridine reductase activity in patients on haemodialysis. New England Journal of Medicine 317: 80\u201384, 1987","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJM198404263101704","volume":"310","author":"SP Andreoli","year":"1984","unstructured":"Andreoli SP, Bergstein JM, Sherrard DJ. Aluminium intoxication from aluminium-containing phosphate binders in children with azotemia not undergoing dialysis. New England Journal of Medicine 310: 1079\u20131084, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0272-6386(87)80056-2","volume":"9","author":"SP Andreoli","year":"1987","unstructured":"Andreoli SP, Dunson JW, Bergstein JM. Calcium carbonate is an effective phophorus binder in children with chronic renal failure. American Journal of Kidney Diseases 9: 206\u2013210, 1987","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM198702053160602","volume":"316","author":"DL Andress","year":"1987","unstructured":"Andress DL, Kopp JB, Maloney NA, Coburn JW, Sherrard DJ. Early deposition of aluminium in bone in diabetic patients on haemodialysis. New England Journal of Medicine 316: 292\u2013296, 1987","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM198502213120803","volume":"312","author":"DL Andress","year":"1985","unstructured":"Andress DL, Ott SM, Maloney NA, Sherrard DJ. Effect of parathyroidectomy on bone aluminium accumulation in chronic renal failure. New England Journal of Medicine 312: 468\u2013473, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0272-6386(85)80087-1","volume":"6","author":"AI Arieff","year":"1985","unstructured":"Arieff AI. Aluminium and the pathogenesis of dialysis encephalopathy. American Journal of Kidney Diseases 6: 317\u2013321, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000184064","volume":"45","author":"RW Balasa","year":"1987","unstructured":"Balasa RW, Murray RL, Kondelis NP, Bischel MD. Phosphate binding properties and electrolyte content of aluminium hydroxide antacids. Nephron 45: 16\u201321, 1987","journal-title":"Nephron"},{"key":"BF03259899_CR17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(83)91273-4","volume":"2","author":"WA Banks","year":"1983","unstructured":"Banks WA, Kastin AJ. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia. Lancet 2: 1227\u20131229, 1983","journal-title":"Lancet"},{"key":"BF03259899_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1445-5994.1975.tb03257.x","volume":"5","author":"LJ Barratt","year":"1975","unstructured":"Barratt LJ, Lawrence JR. Dialysis-associated dementia. Australian and New Zealand Journal of Medicine 5: 62\u201365, 1975","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"BF03259899_CR19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0272-6386(85)80080-9","volume":"6","author":"GM Berlyne","year":"1985","unstructured":"Berlyne GM, Adler AJ. Serum aluminium cannot be measured accurately. American Journal of Kidney Diseases 6: 288\u2013292, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(72)90357-1","volume":"1","author":"GM Berlyne","year":"1972","unstructured":"Berlyne GM, Ben Ari J, Knopf E, Yagil R, Weinberger G, et al. Aluminium toxicity in rats. Lancet 1: 564\u2013568, 1972","journal-title":"Lancet"},{"key":"BF03259899_CR21","first-page":"366","volume":"21","author":"J Bonal","year":"1984","unstructured":"Bonal J, Montoliu J, Lopez Pedret J, et al. Desferrioxamine induced aluminium removal in haemodialysis. Proceedings of the European Dialysis and Transplant Association 21: 366\u2013370, 1984","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1445-5994.1985.tb04060.x","volume":"15","author":"N Boyce","year":"1985","unstructured":"Boyce N, Wood C, Holdsworth S, Thomson NM, Atkins RC. Life-threatening sepsis complicating heavy metal chelation therapy with desferrioxamine. Australian and New Zealand Journal of Medicine 15: 654\u2013655, 1985","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"BF03259899_CR23","first-page":"S20","volume":"24","author":"O Bugiani","year":"1985","unstructured":"Bugiani O, Brancaccio D, Ghetti B. Progressive dialytic encephalopathy and the problem of aluminium neurotoxicity. Clinical Nephrology 24: S20\u2013S25, 1985","journal-title":"Clinical Nephrology"},{"key":"BF03259899_CR24","first-page":"338","volume":"43","author":"MA Burnatowska-Hledin","year":"1984","unstructured":"Burnatowska-Hledin MA, Doyle TM, Eadie M, Mayor GH. 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) increases gastrointestinal (GI) absorption and serum and tissue concentration of aluminium in rats. Federation Proceedings 43: 338, 1984","journal-title":"Federation Proceedings"},{"key":"BF03259899_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0272-6386(85)80079-2","volume":"6","author":"M Burnatowska-Hledin","year":"1985","unstructured":"Burnatowska-Hledin M, Mayor GH. Aluminium: analytical considerations. American Journal of Kidney Diseases 6: 283\u2013287, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR26","first-page":"F192","volume":"249","author":"M Burnatowska-Hledin","year":"1985","unstructured":"Burnatowska-Hledin M, Mayor GH, Lau K. Renal handling of aluminium in the rat: clearance and micropuncture studies. American Journal of Physiology 249: F192\u2013F197, 1985","journal-title":"American Journal of Physiology"},{"issue":"4","key":"BF03259899_CR27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/jcem-49-4-543","volume":"49","author":"CE Cann","year":"1979","unstructured":"Cann CE, Prussin SG, Gordan GS. Aluminium uptake by the parathyroid glands. Journal of Endocrinology and Metabolism 49(4): 543\u2013545, 1979","journal-title":"Journal of Endocrinology and Metabolism"},{"key":"BF03259899_CR28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(83)92192-X","volume":"1","author":"JB Cannata","year":"1983","unstructured":"Cannata JB, Junor BJR, Briggs JD, Fell GS, Beastall G. Effect of acute aluminium overload on calcium and parathyroid-hormone metabolism. Lancet 1: 501\u2013503, 1983","journal-title":"Lancet"},{"key":"BF03259899_CR29","unstructured":"Cases A, Campistol J, Kelly J, et al. Desferoxime induced ocular and auditory neurotoxicity in patients with chronic renal failure. Presented at the 10th International Congress of Nephrology, London, July 1987"},{"key":"BF03259899_CR30","first-page":"358","volume":"3","author":"MJD Cassidy","year":"1988","unstructured":"Cassidy MJD, Swanepoel CR, Bridges S, Marks IN. Does gastric acid secretion affect phosphate binding by aluminium phosphate binding gels in chronic renal failure? Nephrology, Dialysis and Transplantation 3: 358, 1988","journal-title":"Nephrology, Dialysis and Transplantation"},{"key":"BF03259899_CR31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(83)91039-5","volume":"2","author":"TMS Chang","year":"1983","unstructured":"Chang TMS, Barre P. Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis. Lancet 2: 1051\u20131053, 1983","journal-title":"Lancet"},{"key":"BF03259899_CR32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/321570a0","volume":"321","author":"A-M Coriat","year":"1986","unstructured":"Coriat A-M, Gillard RD. Beware the cups that cheer. Nature 321: 570, 1986","journal-title":"Nature"},{"key":"BF03259899_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000408060","volume":"38","author":"R Cornelis","year":"1984","unstructured":"Cornelis R, Schutyser P. Analytical problems related to Al-determination in body fluids, water and dialysate. Contributions to Nephrology 38: 1\u201311, 1984","journal-title":"Contributions to Nephrology"},{"key":"BF03259899_CR34","first-page":"S37","volume":"29","author":"G Cournot-Witmer","year":"1986","unstructured":"Cournot-Witmer G, Plachot JJ, Bourdeau A, et al. Effect of aluminium on bone and cell localisation. Kidney International 29: S37\u2013S40, 1986","journal-title":"Kidney International"},{"key":"BF03259899_CR35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1126\/science.180.4085.511","volume":"180","author":"DR Crapper","year":"1973","unstructured":"Crapper DR, Krishnan SS, Dalton AJ. Brain aluminum distribution in Alzheimer\u2019s disease and experimental neurofibrillary degeneration. Science 180: 511\u2013513, 1973","journal-title":"Science"},{"key":"BF03259899_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/brain\/99.1.67","volume":"99","author":"DR Crapper","year":"1976","unstructured":"Crapper DR, Krishnan SS, Quittkat S. Aluminium, neurofibrillary degeneration and Alzheimer\u2019s disease. Brain 99: 67\u201380,1976","journal-title":"Brain"},{"key":"BF03259899_CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.200.4339.309-a","volume":"200","author":"CS Cronan","year":"1978","unstructured":"Cronan CS, Reiners WA, Reynolds RC, Lang GE. Forest floor leaching: contributions from mineral, organic, and carbonic acids in New Hampshire subalpine forests. Science 200: 309\u2013311, 1978","journal-title":"Science"},{"key":"BF03259899_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.204.4390.304","volume":"204","author":"CS Cronan","year":"1979","unstructured":"Cronan CS, Schofield CL. Aluminium leaching response to acid precipitation: effects on high-elevation watersheds in the Northeast. Science 204: 304\u2013306, 1979","journal-title":"Science"},{"key":"BF03259899_CR39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/324140a0","volume":"324","author":"CS Cronan","year":"1986","unstructured":"Cronan CS, Walker WJ, Bloom PR. Predicting aqueous aluminium concentrations in natural waters. Nature 324: 140\u2013143, 1986","journal-title":"Nature"},{"key":"BF03259899_CR40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","volume":"2","author":"SC Davies","year":"1983","unstructured":"Davies SC, Hungerford JL, Arden GB, et al. Ocular toxicity with high-dose intravenous desferrioxamine. Lancet 2: 181\u2013184, 1983","journal-title":"Lancet"},{"key":"BF03259899_CR41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00490271","volume":"40","author":"U Boni De","year":"1974","unstructured":"De Boni U, Scott JW, Crapper DR. Intracellular aluminium binding: a histochemical study. Histochemistry 40: 31\u201337, 1974","journal-title":"Histochemistry"},{"key":"BF03259899_CR42","first-page":"1086","volume":"2","author":"ME Broe De","year":"1988","unstructured":"De Broe ME, D\u2019Haese PCD, Elseviers MM, Clement J, Visser WJ, et al. Aluminium and end stage renal failure. Nephrology 2: 1086\u20131116, 1988","journal-title":"Nephrology"},{"key":"BF03259899_CR43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.410050615","volume":"5","author":"JF Delaney","year":"1979","unstructured":"Delaney JF. Spinal fluid aluminium levels in patients with Alzheimer disease. Annals of Neurology 5: 580\u2013581, 1979","journal-title":"Annals of Neurology"},{"key":"BF03259899_CR44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/clinchem\/31.1.24","volume":"31","author":"PC D\u2019Haese","year":"1985","unstructured":"D\u2019Haese PC, van der Vyver FL, de Wolff FA, De Broe ME. Measurement of aluminium in serum, blood, urine and tissues of chronic haemodialysed patients by use of electrothermal atomic absorption spectroscopy. Clinical Chemistry 31: 24\u201329, 1985","journal-title":"Clinical Chemistry"},{"key":"BF03259899_CR45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02405308","volume":"36","author":"CR Dunstan","year":"1984","unstructured":"Dunstan CR, Evans RA, Hills E, Wong SYP, Alfrey AC. Effect of aluminium and parathyroid hormone on osteoblasts and bone mineralisation in chronic renal failure. Calcified Tissue International 36: 133\u2013138, 1984","journal-title":"Calcified Tissue International"},{"key":"BF03259899_CR46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0272-6386(87)80015-X","volume":"10","author":"AR Eiser","year":"1987","unstructured":"Eiser AR, Slifkin RF, Neff MS. Intestinal mucormycosis in hemodialysis patients following deferoxamine. American Journal of Kidney Diseases 10: 71\u201373, 1987","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR47","first-page":"157","volume":"15","author":"HL Elliott","year":"1978","unstructured":"Elliott HL, MacDougall AI. Aluminium studies in dialysis encephalopathy. Proceedings of the European Dialysis and Transplant Association 15: 157\u2013163, 1978","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR48","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(78)91654-9","volume":"2","author":"HL Elliot","year":"1978","unstructured":"Elliot HL, MacDougall AI, Haase G, et al. Plasmapheresis in the treatment of dialysis encephalopathy. Lancet 2: 940\u2013941, 1978","journal-title":"Lancet"},{"key":"BF03259899_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jcp.26.2.83","volume":"26","author":"HA Ellis","year":"1973","unstructured":"Ellis HA, Peart KM. Azotaemic renal osteodystrophy: a quantitative study on iliac bone. Journal of Clinical Pathology 26: 83\u2013101, 1973","journal-title":"Journal of Clinical Pathology"},{"key":"BF03259899_CR50","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(86)92340-8","volume":"1","author":"GS Fell","year":"1986","unstructured":"Fell GS, Shenkin A, Halls DJ. Aluminium contamination of intravenous Pharmaceuticals, nutrients, and blood products. Lancet 1: 380, 1986","journal-title":"Lancet"},{"key":"BF03259899_CR51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-96-1-34","volume":"96","author":"AJ Felsenfeld","year":"1982","unstructured":"Felsenfeld AJ, Harrelson TA, Gutman RA, et al. Osteomalacia after parathyroidectomy in patients with uremia. Annals of Internal Medicine 96: 34\u201339, 1982","journal-title":"Annals of Internal Medicine"},{"key":"BF03259899_CR52","first-page":"296","volume-title":"Side-effects of drugs annual 9","author":"PI Folb","year":"1985","unstructured":"Folb PI. Intravenous infusions: solutions and emulsions. In Dukes MNG (Ed.) Side-effects of drugs annual 9, pp. 296\u2013301, Elsevier Scientific Publishers, Amsterdam, 1985"},{"key":"BF03259899_CR53","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/326136b0","volume":"326","author":"J-F Foncin","year":"1987","unstructured":"Foncin J-F. Alzheimer\u2019s disease and aluminium. Nature 326: 136, 1987","journal-title":"Nature"},{"key":"BF03259899_CR54","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/clinchem\/28.11.2259","volume":"11","author":"W Frech","year":"1982","unstructured":"Frech W, Cedergren A, Cederberg C, Vessman J. Evaluation of some critical factors affecting determination of aluminium in blood, plasma, or serum by electrothermal atomic absorption spectroscopy. Clinical Chemistry 11: 2259\u20132263, 1982","journal-title":"Clinical Chemistry"},{"key":"BF03259899_CR55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(85)90463-5","volume":"2","author":"M Freundlich","year":"1985","unstructured":"Freundlich M, Abitbol C, Zilleruelo G, et al. Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet 2: 527\u2013529, 1985","journal-title":"Lancet"},{"key":"BF03259899_CR56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000408070","volume":"38","author":"C Fuchs","year":"1984","unstructured":"Fuchs C, Armstrong VW, Quellhorst E, Scheler F. Prophylaxis and methods for early recognition of aluminium intoxication. Contributions to Nephrology 38: 81\u201391, 1984","journal-title":"Contributions to Nephrology"},{"key":"BF03259899_CR57","volume-title":"Free radicals in biology and medicine","author":"B Halliwell","year":"1985","unstructured":"Halliwell B, Gutteridge JMC. Free radicals in biology and medicine, Clarendon Press, Oxford, 1985"},{"key":"BF03259899_CR58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ki.1984.25","volume":"25","author":"DA Henry","year":"1984","unstructured":"Henry DA, Goodman WG, Nudelman RK, et al. Parenteral aluminium administration in the dog, I: plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. Kidney International 25: 362\u2013369, 1984","journal-title":"Kidney International"},{"key":"BF03259899_CR59","first-page":"223","volume-title":"Aluminium and other trace elements in renal disease","author":"CD Hewitt","year":"1986","unstructured":"Hewitt CD, Ackrill P, Day JP. Copper removal from renal patients using desferrioxamine chelation to reduce aluminium overload. In Taylor A (Ed.) Aluminium and other trace elements in renal disease, pp. 223\u2013227, Bailliere Tindall, London, 1986"},{"key":"BF03259899_CR60","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0140-6736(81)90203-8","volume":"2","author":"KC Hodge","year":"1981","unstructured":"Hodge KC, Day JP, O\u2019Hara M, Ackrill P, Ralston AJ. Critical concentrations of aluminium in water used for dialysis. Lancet 2: 802\u2013803, 1981","journal-title":"Lancet"},{"key":"BF03259899_CR61","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/IAI.40.3.1134-1139.1983","volume":"40","author":"M Holzberg","year":"1983","unstructured":"Holzberg M, Artis WM. Hydroxamate siderophore production by opportunistic and systemic fungal pathogens. Infection and Immunity 40: 1134\u20131139, 1983","journal-title":"Infection and Immunity"},{"key":"BF03259899_CR62","first-page":"439","volume":"56","author":"GA Hudson","year":"1979","unstructured":"Hudson GA, Milne FJ, Oliver NJ, Reis P, Murray J, et al. Bone disease in patients on maintenance haemodialysis using softened or deionised water. South African Medical Journal 56: 439\u2013443, 1979","journal-title":"South African Medical Journal"},{"key":"BF03259899_CR63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0272-6386(85)80083-4","volume":"6","author":"BU Ihle","year":"1985","unstructured":"Ihle BU, Becker GJ. Gastrointestinal absorption of aluminium. American Journal of Kidney Diseases 6: 302\u2013305, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR64","first-page":"195","volume":"19","author":"BU Ihle","year":"1982","unstructured":"Ihle BU, Buchanan MRC, Stevens B, Becker GJ, Kincaid-Smith P. The efficacy of various treatment modalities on aluminium associated bone disease. Proceedings of the European Dialysis and Transplant Association 19: 195\u2013201, 1982","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0272-6386(86)80024-5","volume":"8","author":"AE Jennings","year":"1986","unstructured":"Jennings AE, Bodvarsson M, Galicka-Piskorska G, Diefendorf AS, Simon GM, et al. Use of magnesium hydroxide and low magnesium dialysate does not permit reduction of aluminium hydroxide during continuous ambulatory peritoneal dialysis. American Journal of Kidney Diseases 8: 192\u2013195, 1986","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR66","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.204.4392.497","volume":"204","author":"NM Johnson","year":"1979","unstructured":"Johnson NM. Acid rain: neutralization within the Hubbard Brook ecosystem and regional implications. Science 204: 497\u2013499, 1979","journal-title":"Science"},{"key":"BF03259899_CR67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ki.1977.123","volume":"12","author":"WD Kaehny","year":"1977","unstructured":"Kaehny WD, Alfrey AC, Holman RE, Shorr WJ. Aluminium transfer during hemodialysis. Kidney International 12: 361\u2013365, 1977a","journal-title":"Kidney International"},{"key":"BF03259899_CR68","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM197706162962407","volume":"296","author":"WD Kaehny","year":"1977","unstructured":"Kaehny WD, Hegg AP, Alfrey AC. Gastrointestinal absorption of aluminium from aluminium-containing antacids. New England Journal of Medicine 296: 1389\u20131390, 1977b","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR69","first-page":"83","volume":"1","author":"SJ Karlik","year":"1986","unstructured":"Karlik SJ, Eichorn GL, Crapper-McLachlan DR. Molecular interactions of aluminium with DNA. Neurotoxicology 1: 83\u201388, 1986","journal-title":"Neurotoxicology"},{"key":"BF03259899_CR70","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0272-6386(85)80095-0","volume":"6","author":"M Kaye","year":"1985","unstructured":"Kaye M, Gagnon R. Aluminium and phosphate: the double bind. American Journal of Kidney Diseases 6: 365\u2013367, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR71","first-page":"S58","volume":"29","author":"DNS Kerr","year":"1986","unstructured":"Kerr DNS, Ward MK, Arze RS, et al. Aluminium-induced dialysis osteodystrophy: the demise of \u2018Newcastle Bone Disease\u2019? Kidney International 29: S58\u2013S64, 1986","journal-title":"Kidney International"},{"key":"BF03259899_CR72","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/ajcn\/35.6.1425","volume":"35","author":"GL Klein","year":"1982","unstructured":"Klein GL, Alfrey AC, Miller NL, et al. Aluminium loading during total parenteral nutrition. American Journal of Clinical Nutrition 35: 1425\u20131429, 1982","journal-title":"American Journal of Clinical Nutrition"},{"key":"BF03259899_CR73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/333122a0","volume":"333","author":"KR Koch","year":"1988","unstructured":"Koch KR, Pougnet MAB, De Villiers S, Monteagudo FSE. Increased urinary excretion of Al after drinking tea. Nature 333: 122, 1988","journal-title":"Nature"},{"key":"BF03259899_CR74","first-page":"712","volume":"92","author":"MT Kovalchik","year":"1978","unstructured":"Kovalchik MT, Kaehny WD, Hegg AP, Jackson JT, Alfrey AC. Aluminium kinetics during hemodialysis. Journal of Laboratory and Clinical Medicine 92: 712\u2013720, 1978","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"BF03259899_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408448409029320","volume":"13","author":"GL Krueger","year":"1984","unstructured":"Krueger GL, Morris TK, Suskind RR, Widner EM. The health effects of aluminium compounds in mammals. Critical Reviews in Toxicology 13: 1\u201324, 1984","journal-title":"Critical Reviews in Toxicology"},{"key":"BF03259899_CR76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-2952(80)90321-4","volume":"29","author":"JCK Lai","year":"1980","unstructured":"Lai JCK, Guest JF, Leung TKC, Lim L, Davison AM. The effects of cadmium, manganese and aluminium on sodium-potassium-activated and magnesium-activated adenosine triphosphatase activity and choline uptake in rat brain synaptosomes. Biochemical Pharmacology 29: 141\u2013146, 1980","journal-title":"Biochemical Pharmacology"},{"key":"BF03259899_CR77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/clinchem\/31.1.20","volume":"31","author":"FY Leung","year":"1985","unstructured":"Leung FY, Hodsman AB, Muirhead N, Henderson AR. Ultrafiltration studies in vitro of serum aluminium in dialysis patients after deferoxamine chelation therapy. Clinical Chemistry 31: 20\u201323, 1985","journal-title":"Clinical Chemistry"},{"key":"BF03259899_CR78","first-page":"164","volume":"303","author":"SE Levick","year":"1980","unstructured":"Levick SE. Dementia from aluminium pots? New England Journal of Medicine 303: 164, 1980","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR79","first-page":"923","volume":"314","author":"A Lione","year":"1986","unstructured":"Lione A. More on aluminium in infants. New England Journal of Medicine 314: 923, 1986","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR80","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM198505233122114","volume":"312","author":"EA Loeliger","year":"1985","unstructured":"Loeliger EA, de Wolff FA. Aluminium contamination of albumin-replacement solutions. New England Journal of Medicine 312: 1389\u20131390, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR81","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1001\/archinte.1985.00360110042011","volume":"145","author":"WT Longstreth","year":"1985","unstructured":"Longstreth WT, Rosenstock L, Heyer NJ. Potroom palsy? Neurologic disorder in three aluminium smelter workers. Archives of Internal Medicine 145: 1972\u20131975, 1985","journal-title":"Archives of Internal Medicine"},{"key":"BF03259899_CR82","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bmj.292.6516.306","volume":"292","author":"ER Maher","year":"1986","unstructured":"Maher ER, Brown EA, Curtis JR, Phillips ME, Sampson B. Accumulation of aluminium in chronic renal failure due to administration of albumin replacement solutions. British Medical Journal 292: 306, 1986","journal-title":"British Medical Journal"},{"key":"BF03259899_CR83","first-page":"203","volume-title":"Aluminium and other trace elements in renal disease","author":"F Malberti","year":"1986","unstructured":"Malberti F, Surian M, Colussi G, Poggio F, Minoia C, et al. Desferrioxamine induced aluminium removal in haemodialysis: comparison of different membranes. In Taylor A (Ed.) Aluminium and other trace elements in renal disease, pp. 203\u2013208, Bailliere Tindall, London, 1986"},{"key":"BF03259899_CR84","first-page":"1082","volume":"2","author":"HH Malluche","year":"1988","unstructured":"Malluche HH, Faugere MC. The cellular basis of aluminium bone disease and its relationship to vitamin D metabolism. Nephrology 2: 1082\u20131085, 1988","journal-title":"Nephrology"},{"key":"BF03259899_CR85","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","volume":"9","author":"HH Malluche","year":"1976","unstructured":"Malluche HH, Ritz E, Lange HP, et al. Bone histology in incipient and advanced renal failure. Kidney International 9: 355\u2013362, 1976","journal-title":"Kidney International"},{"key":"BF03259899_CR86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJM198407193110302","volume":"311","author":"HH Malluche","year":"1984","unstructured":"Malluche HH, Smith AJ, Abreo K, Faugere MC. The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure. New England Journal of Medicine 311: 140\u2013144, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-73-3-409","volume":"73","author":"AD Manzler","year":"1970","unstructured":"Manzler AD, Schreiner AW. Copper-induced acute hemolytic anemia: a new complication of hemodialysis. Annals of Internal Medicine 73: 409\u2013412, 1970","journal-title":"Annals of Internal Medicine"},{"key":"BF03259899_CR88","first-page":"114","volume":"6","author":"SG Massry","year":"1986","unstructured":"Massry SG. Prevention and treatment of the abnormalities of divalent ion metabolism in renal failure. Seminars in Nephrology 6: 114\u2013121, 1986","journal-title":"Seminars in Nephrology"},{"key":"BF03259899_CR89","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0272-6386(85)80084-6","volume":"6","author":"GH Mayor","year":"1985","unstructured":"Mayor GH. The case for parathyroid hormone. American Journal of Kidney Diseases 6: 306\u2013308, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR90","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1126\/science.897661","volume":"197","author":"GH Mayor","year":"1977","unstructured":"Mayor GH, Keiser JA, Makdani D, Ku PK. Aluminium absorption and distribution: effect of parathyroid hormone. Science 197: 1187\u20131189, 1977","journal-title":"Science"},{"key":"BF03259899_CR91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ki.1980.5","volume":"17","author":"GH Mayor","year":"1980","unstructured":"Mayor GH, Sprague SM, Hourani MR, Sanchez TV. Parathyroid hormone-mediated aluminium deposition and egress in the rat. Kidney International 17: 40\u201344, 1980","journal-title":"Kidney International"},{"key":"BF03259899_CR92","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(78)90681-5","volume":"1","author":"JR McDermott","year":"1978","unstructured":"McDermott JR, Smith AI, Ward MK, Parkinson IS, Kerr DNS. Brain-aluminium concentration in dialysis encephalopathy. Lancet 1: 901\u2013903, 1978","journal-title":"Lancet"},{"key":"BF03259899_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000183328","volume":"39","author":"RJS McGonigle","year":"1985","unstructured":"McGonigle RJS, Parsons V. Aluminium induced anaemia in haemodialysis patients. Nephron 39: 1\u20139, 1985","journal-title":"Nephron"},{"key":"BF03259899_CR94","first-page":"149","volume":"25","author":"DS Milliner","year":"1984","unstructured":"Milliner DS, Nebeker HG, Ott SA, Sherrard DJ, Andress DL, et al. Desferrioxamine infusion test for diagnosis of aluminium osteomalacia. Kidney International 25: 149, 1984","journal-title":"Kidney International"},{"key":"BF03259899_CR95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM198501173120307","volume":"312","author":"DS Milliner","year":"1985","unstructured":"Milliner DS, Shinaberger JH, Shuman P, Coburn JW. Inadvertent aluminium administration during plasma exchange due to aluminium contamination of albumin-replacement solutions. New England Journal of Medicine 312: 165\u2013167, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR96","first-page":"955","volume":"61","author":"FJ Milne","year":"1982","unstructured":"Milne FJ, Hudson GA, Meyers AM, et al. Healing of fracturingbone disease occurring in patients on dialysis. South African Journal of Medicine 61: 955\u2013959, 1982","journal-title":"South African Journal of Medicine"},{"key":"BF03259899_CR97","first-page":"202","volume":"20","author":"FJ Milne","year":"1983","unstructured":"Milne FJ, Sharf B, Bell P, Meyers AM. The effect of low aluminium water and desferrioxamine on the outcome of dialysis encephalopathy. Clinical Nephrology 20: 202\u2013207, 1983","journal-title":"Clinical Nephrology"},{"key":"BF03259899_CR98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000185064","volume":"49","author":"FSE Monteagudo","year":"1988","unstructured":"Monteagudo FSE, Isaacson LC, Wilson G, Hickman R, Folb PI. Aluminium excretion by the distal tubule of the pig kidney. Nephron 49: 245\u2013250, 1988","journal-title":"Nephron"},{"key":"BF03259899_CR99","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jca.2920030306","volume":"3","author":"FSE Monteagudo","year":"1987","unstructured":"Monteagudo FSE, Wood L, Jacobs P, Folb PI, Cassidy M. Aluminium loading during therapeutic plasma exchange. Journal of Clinical Apheresis 3: 161\u2013163, 1987","journal-title":"Journal of Clinical Apheresis"},{"key":"BF03259899_CR100","first-page":"332","volume":"207","author":"P F Mora","year":"1983","unstructured":"Mora Palma FJ, Ellis HA, Cook DB, et al. Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Quarterly Journal of Medicine 207: 332\u2013348, 1983","journal-title":"Quarterly Journal of Medicine"},{"key":"BF03259899_CR101","first-page":"404A","volume":"32","author":"J Morrissey","year":"1984","unstructured":"Morrissey J. The influence of phorbol myristate acetate (PMA) on parathyroid hormone secretion. Clinical Research 32: 404A, 1984","journal-title":"Clinical Research"},{"key":"BF03259899_CR102","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.1983.81","volume":"23","author":"J Morrissey","year":"1983","unstructured":"Morrissey J, Rothstein M, Mayor G, Slatopolsky E. Suppression of parathyroid hormone secretion by aluminium. Kidney International 23: 699\u2013704, 1983","journal-title":"Kidney International"},{"key":"BF03259899_CR103","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/ki.1986.6","volume":"29","author":"J Morrissey","year":"1986","unstructured":"Morrissey J, Slatopolsky E. Effect of aluminium on parathyroid hormone secretion. Kidney International 29: S41\u2013S44, 1986","journal-title":"Kidney International"},{"key":"BF03259899_CR104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0272-6386(86)80154-8","volume":"8","author":"N Muirhead","year":"1986","unstructured":"Muirhead N, Hollomby DJ, Leung FY, et al. Removal of aluminium during hemodialysis: effect of different dialyzer membranes. American Journal of Kidney Disease 8: 51\u201355, 1986","journal-title":"American Journal of Kidney Disease"},{"key":"BF03259899_CR105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(85)90254-5","volume":"2","author":"KP Nordal","year":"1985","unstructured":"Nordal KP, Taslseth T, Dahl E, et al. Aluminium overload, a predisposing condition for epileptic seizures in renal transplant patients treated with cyclosporin? Lancet 2: 153\u2013154, 1985","journal-title":"Lancet"},{"key":"BF03259899_CR106","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1126\/science.232.4746.54","volume":"232","author":"DK Nordstrom","year":"1986","unstructured":"Nordstrom DK, Ball JW. The geochemical behavior of aluminium in acidified surface waters. Science 232: 54\u201356, 1986","journal-title":"Science"},{"key":"BF03259899_CR107","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJM198203183061107","volume":"306","author":"JA O\u2019Hare","year":"1982","unstructured":"O\u2019Hare JA, Murnaghan DJ. Reversal of aluminium-induced hemodialysis anemia by a low-aluminium dialysate. New England Journal of Medicine 306: 654\u2013656, 1982","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR108","first-page":"305","volume":"23","author":"R Ondreicka","year":"1966","unstructured":"Ondreicka R, Ginter E, Kortus J. Chronic toxicity of aluminium in rats and mice and its effects on phosphorus metabolism. British Journal of Industrial Medicine 23: 305\u2013312, 1966","journal-title":"British Journal of Industrial Medicine"},{"key":"BF03259899_CR109","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0272-6386(85)80082-2","volume":"6","author":"SM Ott","year":"1985","unstructured":"Ott SM. Aluminium accumulation in individuals with normal renal function. American Journal of Kidney Disease 6: 297\u2013301, 1985","journal-title":"American Journal of Kidney Disease"},{"key":"BF03259899_CR110","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198209163071202","volume":"307","author":"SM Ott","year":"1982","unstructured":"Ott SM, Maloney NA, Coburn JW, Alfrey AC, Sherrard DJ. The prevalence of bone aluminium deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. New England Journal of Medicine 307: 709\u2013713, 1982","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR111","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7326\/0003-4819-98-6-910","volume":"98","author":"SM Ott","year":"1983","unstructured":"Ott SM, Maloney NA, Klein GL, et al. Aluminium is associated with low bone formation in patients receiving chronic parenteral nutrition. Annals of Internal Medicine 98: 910\u2013914, 1983","journal-title":"Annals of Internal Medicine"},{"key":"BF03259899_CR112","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(79)90883-3","volume":"1","author":"IS Parkinson","year":"1979","unstructured":"Parkinson IS, Ward MK, Feest TG, Fawcett RWP, Kerr DNS. Fracturing dialysis osteodystrophy and dialysis encephalopathy: an epidemiological survey. Lancet 1: 406\u2013409, 1979","journal-title":"Lancet"},{"key":"BF03259899_CR113","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0009-8981(82)90189-9","volume":"125","author":"IS Parkinson","year":"1982","unstructured":"Parkinson IS, Ward MK, Kerr DNS. A method for the routine determination of aluminium in serum and water by flameless atomic absorption spectrometry. Clinica Chimica Acta 125: 125\u2013133, 1982","journal-title":"Clinica Chimica Acta"},{"key":"BF03259899_CR114","first-page":"1407","volume-title":"Histochemistry: theoretical and applied","author":"AGE Pearce","year":"1972","unstructured":"Pearce AGE. Histochemistry: theoretical and applied, 3rd ed., Vol. 2, pp. 1407\u20131408, Churchill Livingstone, Edinburgh, 1972","edition":"3rd"},{"key":"BF03259899_CR115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.7367858","volume":"208","author":"DP Perl","year":"1980","unstructured":"Perl DP, Brody AR. Alzheimer\u2019s disease: x-ray spectrometric evidence of aluminium accumulation in neurofibrillary tangle-bearing neurons. Science 208: 297\u2013299, 1980","journal-title":"Science"},{"key":"BF03259899_CR116","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.7112111","volume":"217","author":"DP Perl","year":"1982","unstructured":"Perl DP, Gajdusek DC, Garruto RM, Yanagihara RT, Gibbs CJ Jr. Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217: 1053\u20131055, 1982","journal-title":"Science"},{"key":"BF03259899_CR117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ki.1980.117","volume":"18","author":"AM Pierides","year":"1980","unstructured":"Pierides AM, Edwards WG, Cullum UX, McCall JT, Ellis HA. Haemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney International 18: 115\u2013124, 1980","journal-title":"Kidney International"},{"key":"BF03259899_CR118","first-page":"223","volume":"15","author":"MM Platts","year":"1981","unstructured":"Platts MM, Anastassiades E. Dialysis encephalopathy: precipitating factors and improvement in prognosis. Clinical Nephrology 15: 223\u2013228, 1981","journal-title":"Clinical Nephrology"},{"key":"BF03259899_CR119","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(81)91363-5","volume":"2","author":"H Pogglitsch","year":"1981","unstructured":"Pogglitsch H, Petek W, Wawschinek O, Holzer W. Treatment of early stages of dialysis encephalopathy by aluminium depletion. Lancet 2: 1344\u20131345, 1981","journal-title":"Lancet"},{"key":"BF03259899_CR120","first-page":"S17","volume":"29","author":"AS Posner","year":"1986","unstructured":"Posner AS, Blumenthal NC, Boskey AL. Model of aluminium-induced osteomalacia: inhibition of apatite formation and growth. Kidney International 29: S17\u2013S19, 1986","journal-title":"Kidney International"},{"key":"BF03259899_CR121","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0140-6736(86)91457-1","volume":"2","author":"JWL Puntis","year":"1986","unstructured":"Puntis JWL, Hall K, Booth IW. Plasma aluminium and prolonged parenteral nutrition in infancy. Lancet 2: 1332\u20131333, 1986","journal-title":"Lancet"},{"key":"BF03259899_CR122","first-page":"360","volume":"21","author":"H Rahman","year":"1984","unstructured":"Rahman H, Channon SM, Skillen AW, Ward MK, Kerr DNS. Protein binding of aluminium in normal subjects and in patients with chronic renal failure. Proceedings of the European Dialysis and Transplant Association 21: 360\u2013365, 1984","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR123","first-page":"810","volume":"90","author":"RR Recker","year":"1977","unstructured":"Recker RR, Blotcky AJ, Leffler JA, Rack EP. Evidence for aluminium absorption from the gastrointestinal tract and bone deposition by aluminium carbonate ingestion with normal renal function. Journal of Laboratory and Clinical Medicine 90: 810\u2013815, 1977","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"BF03259899_CR124","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0140-6736(83)91136-4","volume":"2","author":"RM Robins-Browne","year":"1983","unstructured":"Robins-Browne RM, Prpic JK. Desferrioxamine and systemic yersiniosis. Lancet 2: 1372, 1983","journal-title":"Lancet"},{"key":"BF03259899_CR125","first-page":"725","volume":"20","author":"H Schneider","year":"1983","unstructured":"Schneider H, Kulbe KD, Weber H, Streicher E. High-effective aluminium free phosphate binder: in vitro and in vivo studies. Proceedings of the European Dialysis and Transplant Association 20: 725\u2013729, 1983","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR126","first-page":"125","volume":"7","author":"A Schwarzbeck","year":"1977","unstructured":"Schwarzbeck A, Wagner L, Squarr H-U, Strauch M. Clotting in dialyzers due to low pH of dialysis fluid. Clinical Nephrology 7: 125\u2013127, 1977","journal-title":"Clinical Nephrology"},{"key":"BF03259899_CR127","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM198505233122101","volume":"312","author":"AB Sedman","year":"1985","unstructured":"Sedman AB, Klein GL, Merritt RJ, et al. Evidence of aluminium loading in infants receiving intravenous therapy. New England Journal of Medicine 312: 1337\u20131343, 1985","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR128","first-page":"971","volume":"15","author":"D Shore","year":"1980","unstructured":"Shore D, Millson M, Holtz JL, King SW, Bridge TP, et al. Serum aluminium in primary degenerative dementia. Biological Psychiatry 15: 971\u2013977, 1980","journal-title":"Biological Psychiatry"},{"key":"BF03259899_CR129","first-page":"230","volume":"8","author":"FB Siebert","year":"1929","unstructured":"Siebert FB, Wells HG. The effect of aluminium on mammalian blood and tissues. Archives of Pathology 8: 230\u2013261, 1929","journal-title":"Archives of Pathology"},{"key":"BF03259899_CR130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-4838(83)90337-0","volume":"744","author":"N Siegel","year":"1983","unstructured":"Siegel N, Haug A. Aluminium interaction with calmodulin: evidence for altered structure and function from optical and enzymatic studies. Biochimica Biophysica Acta 744: 36\u201345, 1983","journal-title":"Biochimica Biophysica Acta"},{"key":"BF03259899_CR131","unstructured":"Simon P, Allain P, Ang KS, Cam G, Mauras Y. Higher performance of polyacrylonitrile dialyser than cuprophan hollow fiber dialyser to remove aluminium (Al) by hemodialysis alone and following chelation with desferrioxamine (DFX). Abstract. Symposium on Aluminium and Renal Failure, Antwerp, 1981"},{"key":"BF03259899_CR132","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0140-6736(83)90537-8","volume":"2","author":"P Simon","year":"1983","unstructured":"Simon P, Ang KS, Meyrier A, Allain P, Mauras Y. Desferrioxamine, ocular toxicity, and trace metals. Lancet 2: 512\u2013513, 1983","journal-title":"Lancet"},{"key":"BF03259899_CR133","first-page":"129","volume-title":"Blood purification in perspective: new insights and future trends","author":"P Simon","year":"1987","unstructured":"Simon P, Cam G, Ang KS. Frequency of aluminium intoxication in a dialyzed population. In Man et al. (Eds) Blood purification in perspective: new insights and future trends, pp. 129\u2013131, ISAO Press, Cleveland, 1987"},{"key":"BF03259899_CR134","first-page":"933","volume":"76","author":"KM Six","year":"1970","unstructured":"Six KM, Goyer RA. Experimental enhancement of lead toxicity by low dietary calcium. Journal of Laboratory and Clinical Medicine 76: 933\u2013942, 1970","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"BF03259899_CR135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1973.92","volume":"4","author":"E Slatopolsky","year":"1973","unstructured":"Slatopolsky E, Briker NS. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney International 4: 141\u2013145, 1973","journal-title":"Kidney International"},{"key":"BF03259899_CR136","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","volume":"315","author":"E Slatopolsky","year":"1986","unstructured":"Slatopolsky E, Weerts C, Lopez-Hilker S, et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. New England Journal of Medicine 315: 157\u2013161, 1986","journal-title":"New England Journal of Medicine"},{"key":"BF03259899_CR137","first-page":"1264","volume":"7","author":"EC Smith","year":"1978","unstructured":"Smith EC, Mahurkar SD, Mamdani BH, Dunea G. Diagnosing dialysis dementia. Dialysis and Transplantation 7: 1264\u20131274, 1978","journal-title":"Dialysis and Transplantation"},{"key":"BF03259899_CR138","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(01)24927-7","volume":"1","author":"J Spofforth","year":"1921","unstructured":"Spofforth J. Case of aluminium poisoning. Lancet 1: 1301, 1921","journal-title":"Lancet"},{"key":"BF03259899_CR139","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0272-6386(85)80094-9","volume":"6","author":"RD Swartz","year":"1985","unstructured":"Swartz RD. Deferoxamine and aluminium removal. American Journal of Kidney Diseases 6: 358\u2013364, 1985","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR140","first-page":"101","volume":"22","author":"RD Swartz","year":"1985","unstructured":"Swartz RD, Domdrouski J, Burnatowska-Hledin M, Mayor GH. Microcytic anaemia: a marker for the diagnosis of aluminium toxicity. Proceedings of the European Dialysis and Transplant Association 22: 101\u2013105, 1985","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR141","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(84)92399-7","volume":"1","author":"G Theriault","year":"1984","unstructured":"Theriault G, Cordier S, Tremblay C, Gingras S. Bladder cancer in the aluminium industry. Lancet 1: 947\u2013950, 1984","journal-title":"Lancet"},{"key":"BF03259899_CR142","first-page":"295","volume":"19","author":"M Touam","year":"1983","unstructured":"Touam M, Martinez F, Lacour B, Bourdon R, Zingraff J, et al. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies. Clinical Nephrology 19: 295\u2013298, 1983","journal-title":"Clinical Nephrology"},{"key":"BF03259899_CR143","first-page":"182","volume":"74","author":"J Turkstra","year":"1978","unstructured":"Turkstra J, Beukes PJL, Brits RJN, Hambleton-Jones BB. Multielement characterisation of human hair by neutron activation analysis. South African Journal of Science 74: 182\u2013184, 1978","journal-title":"South African Journal of Science"},{"key":"BF03259899_CR144","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0272-6386(88)80175-6","volume":"11","author":"MW Turner","year":"1988","unstructured":"Turner MW, Ardila M, Hutchinson T, Prichard S, Barre PE, et al. Sporadic aluminium osteomalacia: identification of patients at risk. American Journal of Kidney Diseases 11: 51\u201356, 1988","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259899_CR145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/096032718500400613","volume":"4","author":"GB Voet Van der","year":"1985","unstructured":"Van der Voet GB, de Wolff FA. Distribution of aluminium between plasma and erythrocytes. Human Toxicology 4: 643\u2013648, 1985","journal-title":"Human Toxicology"},{"key":"BF03259899_CR146","first-page":"388","volume":"22","author":"K Wagner","year":"1985","unstructured":"Wagner K, Lenz T, Keller F, et al. Does desferrioxamine induce aluminium load in patients on chronic haemodialysis? Proceedings of the European Dialysis and Transplant Association 22: 388\u2013391, 1985","journal-title":"Proceedings of the European Dialysis and Transplant Association"},{"key":"BF03259899_CR147","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(78)90191-5","volume":"1","author":"MK Ward","year":"1978","unstructured":"Ward MK, Ellis HA, Feest TG, et al. Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminium. Lancet 1: 841\u2013845, 1978","journal-title":"Lancet"},{"key":"BF03259899_CR148","first-page":"38","volume":"4","author":"RA Wascher","year":"1985","unstructured":"Wascher RA, Cohn JB. The differential diagnosis of Alzheimer\u2019s disease. Geriatric Medicine Today 4: 38\u201348, 1985","journal-title":"Geriatric Medicine Today"},{"key":"BF03259899_CR149","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0028-1095783","volume":"11","author":"PW Washko","year":"1979","unstructured":"Washko PW, Cousins RJ. Effect of parathyroid hormone on the uptake of orally administered cadmium. Hormone and Metabolic Research 11: 378, 1979","journal-title":"Hormone and Metabolic Research"},{"key":"BF03259899_CR150","first-page":"122","volume":"1","author":"DC Wheeler","year":"1986","unstructured":"Wheeler DC, Beaman M, Warwick G, Walls J. Magnesium hydroxide as a phosphate binder in CAPD patients with elevated serum aluminium levels. Nephrology Dialysis and Transplantation 1: 122, 1986","journal-title":"Nephrology Dialysis and Transplantation"},{"key":"BF03259899_CR151","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-104-6-782","volume":"104","author":"J W Williams","year":"1966","unstructured":"Williams J W, Vera SR, Peters TG, et al. Biliary excretion of aluminium in aluminium osteodystrophy with liver disease. Annals of Internal Medicine 104: 782\u2013785, 1966","journal-title":"Annals of Internal Medicine"},{"key":"BF03259899_CR152","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-107-5-678","volume":"107","author":"DW Windus","year":"1987","unstructured":"Windus DW, Stokes TJ, Julian BA, Fenves AZ. Fatal rhizopus infections in hemodialysis patients receiving deferoxamine. Annals of Internal Medicine 107: 678\u2013680, 1987","journal-title":"Annals of Internal Medicine"},{"key":"BF03259899_CR153","first-page":"190","volume":"1","author":"AJ Wing","year":"1980","unstructured":"Wing AJ, Brunner FP, Brynger H, et al. Dialysis dementia in Europe: report from the Registration Committee of the European Dialysis and Transplant Association. Lancet 1: 190\u2013192, 1980","journal-title":"Lancet"},{"key":"BF03259899_CR154","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00005072-197004000-00001","volume":"29","author":"H Wisniewski","year":"1970","unstructured":"Wisniewski H, Terry RD, Hirano A. Neurofibrillary pathology. Journal of Neuropathology and Experimental Neurology 29: 163\u2013176, 1970","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"BF03259899_CR155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0162-0134(00)80005-7","volume":"14","author":"PCL Wong","year":"1981","unstructured":"Wong PCL, Lai JCK, Lim L, Davison AM. Selective inhibition of L-glutamate and gamma-aminobutyrate transport in nerve ending particles by aluminium, manganese and cadonium chloride. Journal of Inorganic Biochemistry 14: 253\u2013260, 1981","journal-title":"Journal of Inorganic Biochemistry"},{"issue":"1","key":"BF03259899_CR156","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/scientificamerican0185-62","volume":"252","author":"RJ Wurtman","year":"1985","unstructured":"Wurtman RJ. Alzheimer\u2019s disease. Scientific American 252(1): 48\u201356, 1985","journal-title":"Scientific American"},{"key":"BF03259899_CR157","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(80)90458-8","volume":"197","author":"CM Yates","year":"1980","unstructured":"Yates CM, Simpson J, Russell D, Gordon A. Cholinergic enzymes in neurofibrillary degeneration produced by aluminium. Brain Research 197: 269\u2013274, 1980","journal-title":"Brain Research"},{"key":"BF03259899_CR158","unstructured":"Zoller KA, Andress DI, Caliscibetta CC, et al. Fatal disseminated phycomycosis (mucormycosis) during desferoxamine therapy of aluminium toxicity: report of 3 cases. Presented at 10th International Congress of Nephrology, London, July 1987"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259899.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259899\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:33:00Z","timestamp":1594956780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,2]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,2]]}},"alternative-id":["BF03259899"],"URL":"https:\/\/doi.org\/10.1007\/bf03259899","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1989,2]]}}}